Wednesday, June 19, 2013

Serving patients is a privilege that comes with responsibilities...

Our Mission:

 Protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain

Partnership For Safe Medicines Safety Tips for Doctors and Patients

Hand tipEducate your  organization members on the dangers of counterfeit medicines, but also teach them how to keep safe from dangerous fake drugs. We have 25 tips for patients and another 27 for doctors and other healthcare providers that you can share with your members in your newsletters, on your facebook page, on twitter, and on your website.

Download the art, tips and tweets for doctors or patients today and share!


Rx-360 Releases Two New Supply Chain Security White Papers

 

Rx-360 White Paper on Illegal Diversion of Pharmaceuticals: contextualize the causes and impact of illegal diversion with case studies specific to this issue. Successful mitigation strategies for illegal diversion within the global pharmaceutical supply chain will be highlighted.  To read the White paper go to: 
http://hosted-p0.vresp.com/427409/9a6cffc96f/ARCHIVE

 

Rx-360 White Paper on Mitigating Risk to the Supply Chain - Drug Shortage Working Group reviews some potential mitigation steps for companies to consider if they have a drug shortage to prevent criminals from exploiting the shortage. To read the White paper go to: 
http://hosted-p0.vresp.com/427409/28d02cb4c8/ARCHIVE

 

 

Rx-360 Congratulates FDA and Deb Autor for Developing and Sharing Counterfeit Detectors to Aid Battle Against Malaria 

Deborah M. Autor
 

Somewhere right now, malaria patients facing a life-threatening illness are being treated with counterfeit or substandard anti-malarial drugs, including falsified products, that threaten their recovery and can contribute to drug resistance. We are proud to announce the Food and Drug Administration’s launch of a partnership that will use a clever, innovative tool invented by FDA scientists to quickly and cheaply test suspect counterfeit or substandard anti-malarial drugs, including falsified products. The partnership will test the effectiveness of this hand-held, battery-operated tool, called Counterfeit Detection Device, Version 3, or, simply, CD-3. It will be deployed first in Ghana and then, after data is collected, in a second testing region. Read More

 

   

Rx-360 Rleases New Smart Phone APP for Android Phones, IPads and IPhones

Today, Rx-360 is proud to announce the launch of IPad and IPhone Apps that provide everything that you may need to know about the pharmaceutical supply chain and the quality of material within the supply chain.

 

                                                                                                          

 

 

woodcok               

 A Thought Provoking Article Aimed at Reducing Shortages
"Economic and technological drivers of generic sterile injectable drug shortages"

Over the past few years, an increasing number of critically needed medicines have been in short supply. Using economic theory to frame the drug-shortage problem, this paper explores why and how manufacturing-quality problems could combine with other economic and technological factors to result in shortages of generic sterile injectable drugs. 

To read the entire article, click here

 


 

 


 Join Our Members and Your Colleagues Protecting Patients

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

  

 

Eli Lilly

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

Enough talk,

it is now time for decisive action.

Join Rx-360 Today! 

<<
[1/85]Members
[2/85]Rx-360
[3/85]Abbvie
[4/85]Alcon
[5/85]Amgen
[6/85]AMPAC
[7/85]Amylin
[8/85]APIC
[10/85]AstraZeneca
[11/85]Aurisco
[12/85]Avantor
[13/85]BASF
[14/85]Baxter
[15/85]Bayer
[16/85]Bergamo
[17/85]Biogen
[19/85]BI
[20/85]BMS
[22/85]Cardinal
[23/85]Centocor
[24/85]Cephalon
[25/85]CRN
[27/85]Doe Ingalls
[28/85]DSM
[29/85]EFCG
[30/85]EGA
[32/85]Eli Lilly
[33/85]Forest Labs
[35/85]GSK
[36/85]GE
[37/85]Genentech
[38/85]Hikal
[39/85]Hospira
[40/85]Hovione
[41/85]IPEC
[42/85]JnJ
[43/85]Janssen
[44/85]LaboChim
[46/85]LifeConEx
[47/85]Ligand
[48/85]McNeil
[49/85]MSD
[50/85]Merck
[52/85]Members
[53/85]MultiPharma
[54/85]MN
[55/85]Mylan
[56/85]Myoderm
[57/85]Novartis
[58/85]Novozymes
[59/85]OSO
[60/85]NSD
[61/85]PDA
[62/85]Perrigo
[63/85]Pfizer
[64/85]PhRMA
[65/85]PSC
[66/85]PQG
[67/85]RCA
[68/85]Rephine
[69/85]RMC
[70/85]Roche
[71/85]Sandoz
[72/85]Safis
[73/85]Sartorius
[74/85]Schering
[76/85]Spectrum
[77/85]SQA Services
[78/85]STS
[79/85]Takeda
[80/85]ucb
[81/85]VWR
[82/85]Watson
[85/85]Membership

 

 

To View or Download the Presentation 
Click on the Slide Above

To see other presentations, click here

 

 

 


Additional Resources to Help Fight for Patient Safety

 

 

The Partnership for Safe Medicines

 

 Home

<<
[1/7]PSI
[2/7]IPQ
[5/7]APIC
[6/7]PCSC
[7/7]IPEC
Events Minimize
Event StartEvent EndTitle

    

ABC News Report on Counterfeits Minimize
ABC News
  

60 Minutes Investigates Counterfeit Drugs Minimize
60 Minutes Report
  

Counterfeit Avastin Video Minimize
Counterfeit Avastin
  


Daily News
(To Read More, Click on the Title of the Article Below)

 


 

2009 © Rx-360